Compound or salt of this with acidic compound, plant growth regulator composed of them, and method for producing the compound

Compounds represented by specific formulas metabolize into IBA within plants, addressing IBA's instability by promoting lateral root formation and elongation, providing a sustainable plant growth regulatory solution.

JP2024163969APending Publication Date: 2024-11-26KANAGAWA UNIVERSITY
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
JP2023079739
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-14
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Indole-3-butyric acid (IBA), a plant growth regulator, is metabolically unstable and quickly converted into indole-3-acetic acid (IAA) within plants, limiting its sustained use in plant growth regulation, with no known synthetic analogues that can effectively replace its functions.

Method used

Development of compounds represented by specific general formulas or their acidic salts that are metabolized within plants to convert into IBA, providing a continuous supply and acting as plant growth regulators by promoting lateral root formation and elongation.

Benefits of technology

These compounds effectively promote lateral root formation and elongation in plants by being metabolized into IBA, offering a sustainable alternative to IBA's growth regulatory effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024163969000001_ABST
    Figure 2024163969000001_ABST
Patent Text Reader

Abstract

To provide an IBA precursor compound capable of continuously supplying IBA by utilizing metabolism within the plant body, and a plant growth regulator including the same.SOLUTION: A compound represented by the general formula (1) or a salt of this with an acidic compound may be applied as a plant growth regulator, where each R1 independently represents an amino group, a halogen atom, a nitro group, a C1-5 alkyl group, a hydroxy group or an alkoxy group; A represents -OR2 or -O-X+; R2 represents H or an alkyl group; X+ represents Li+, Na+, K+, NH4+ or N+R54; for R3 and R4, when one is H, the other is a hydroxyl group or an amino group, or both form a (=O) group together; each R5 independently represents H or an alkyl group with 5 or fewer carbon atoms; and n represents an integer of 0-4.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a compound or a salt of the compound with an acidic compound, a plant growth regulator comprising the compound or the salt, and a method for producing the compound. [Background technology]

[0002] Auxins are plant hormones that are known to be involved in plant development, growth, differentiation, and various environmental responses. Indole-3-acetic acid (IAA) is known to be the most widely distributed natural auxin. Other natural auxins include indole-3-butyric acid (IBA) and 4-chloroindole-3-acetic acid (4-CI-IAA).

[0003] The main natural auxins, IAA and IBA, are chemically unstable, and within the plant body, there is a metabolic pathway for IAA that breaks it down. Therefore, it is not necessarily practical to apply IAA to plants for the purpose of regulating plant growth, and synthetic auxins are widely used as pesticides or chemical plant regulators. Known synthetic auxins include 2,4-dichlorophenoxyacetic acid (2,4-D), 1-naphthaleneacetic acid (NAA), and 2-methyl-4-chlorophenoxybutyric acid (MCPB). For example, 2,4-D is used as a herbicide and a plant tissue culture reagent, and MCPB is used as a selective herbicide for broadleaf weeds in paddy fields.

[0004] On the other hand, IBA is a plant growth regulator that has activities such as growth effects, rooting promotion, cell elongation promotion, and cambium cell division induction, and is used for plant tissue culture, etc. Here, IBA is known to be interconverted with IAA in the auxin biosynthesis pathway, and the conversion from IBA to IAA is said to occur by β-oxidation (see, for example, Non-Patent Document 1). For this reason, IBA has traditionally been thought to exert these effects via IAA, but recently, it has been reported that IBA has a unique effect, for example, that IBA controls the formation of lateral roots during the early growth of plants (see Non-Patent Document 2). [Prior art documents] [Non-patent literature]

[0005] [Non-Patent Document 1] Mashiguchi, K. et al., 2011, Proc. Natl. Acad. Sci. USA, Vol. 108, p. 18512-18517 [Non-Patent Document 2] Woodward A and Bartel B., 2005, Annals of Botany, Vol. 95, p. 707-735 Summary of the Invention [Problem to be solved by the invention]

[0006] As mentioned above, IBA has activities such as growth effects, root promotion, cell elongation promotion, and cambium cell division induction, as well as unique effects such as promoting the formation and elongation of lateral roots, so its practical applications are expected. However, as mentioned above, IBA is metabolically unstable, being converted to IAA and metabolically decomposed within the plant body, and unlike IAA, no synthetic analogues with long-lasting effects are known. For these reasons, the practical applications of IBA have not progressed.

[0007] The present invention has been made in consideration of the above circumstances, and aims to provide an IBA precursor compound that can continuously supply IBA by utilizing metabolism in the plant body, and a plant growth regulator comprising the same. [Means for solving the problem]

[0008] As a result of intensive research aimed at solving the above problems, the present inventors have found that a compound represented by the following general formula (1) or a salt of the compound with an acidic compound has an effect of promoting the formation and elongation of lateral roots in a plant body, similar to IBA, and have confirmed that these compounds are converted to IBA through metabolism in the plant body. The present invention was made based on these findings and provides the following.

[0009] (1) The present invention relates to a compound represented by the following general formula (1) or a salt thereof with an acidic compound: [ka] (In the above general formula (1), each R 1 each independently represents an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; A represents -OR 2 or -O - X + and R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and X + Li + , Na + , K + , NH4 + Or N + R 5 4, and R 3 and R 4 provided that one of them is a hydrogen atom and the other is a hydroxyl group or an amino group, or together they form an (=O) group, and each R 5 are each independently a hydrogen atom or an alkyl group having 5 or less carbon atoms, and n is an integer of 0 to 4.

[0010] (2) The present invention also relates to a compound represented by any one of the following chemical formulas or a salt thereof with an acidic compound. [ka]

[0011] (3) The present invention also relates to a compound represented by any one of the following chemical formulas or a salt thereof with an acidic compound. [ka]

[0012] (4) The present invention also relates to a plant growth regulator comprising the compound according to any one of (1) to (3) or a salt thereof with an acidic compound.

[0013] (5) The present invention also relates to the plant growth regulator according to (4), wherein the plant growth is the formation or elongation of lateral roots and root hairs.

[0014] (6) The present invention also relates to a method for producing the compound according to item (1), comprising the steps of: (a) sequentially carrying out the following steps (a) to (c): Step (a): A step of obtaining a compound represented by the following general formula (C) by cross-coupling compounds represented by the following general formulas (A) and (B): [ka] (In general formula (A), R 1 is an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms, X is a halogen atom, R p is a hydrogen atom or a protecting group for the nitrogen of the indole ring, and n is an integer of 0 to 4. [ka] (In general formula (B), R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and R 3p is a hydroxyl group or an amino group which may have a protecting group. [ka] (In general formula (C), R 1 is an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms, and R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and R 3p is a hydroxyl group or an amino group which may have a protecting group, R p is a hydrogen atom or a protecting group for the nitrogen of the indole ring, and n is an integer of 0 to 4. Step (b): A step of obtaining a compound represented by the following general formula (D) by reducing the compound represented by the general formula (C): [ka] (In general formula (D), R 1 is an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms, and R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and R 3p is a hydroxyl group or an amino group which may have a protecting group, R p is a hydrogen atom or a protecting group for the nitrogen of the indole ring, and n is an integer of 0 to 4. Step (c): In the compound represented by the general formula (D), R p is a hydrogen atom, and R 3p In the case where the hydroxyl group or amino group represented by the formula (I) does not have a protecting group, this step is not carried out. In other cases, the compound represented by the formula (D) is deprotected to obtain a compound represented by the formula (E) below. [ka] (In general formula (E), R 1 is an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms, and R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and R 3is a hydroxyl group or an amino group, and n is an integer of 0 to 4.

[0015] (7) The present invention also relates to a method for producing the compound according to item (1), comprising the steps of: (d) to (f) in this order: Step (d): A step of obtaining a compound represented by the following general formula (G) by reducing a compound represented by the following general formula (F): [ka] (In general formula (F), each R 1 are each independently an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; R p is a protecting group for the indole ring nitrogen, and R 6 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and n is an integer of 0 to 4. [ka] (In general formula (G), each R 1 are each independently an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; R p is a protecting group for the indole ring nitrogen, and n is an integer of 0 to 4. Step (e): A step of obtaining a compound represented by the following general formula (H) by reacting a compound represented by the general formula (G) with a cyanide anion. [ka] (In general formula (H), each R 1 are each independently an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; R p is a protecting group for the indole ring nitrogen, and n is an integer of 0 to 4. Step (f): A step of hydrolyzing a cyano group present in a compound represented by the general formula (H) by reacting the compound represented by the general formula (H) with an acid or a base in the presence or absence of an alcohol having 1 to 5 carbon atoms to obtain a compound represented by the following general formula (I): [ka] (In general formula (I), R 1 is an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms, and R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and n is an integer of 0 to 4. Effect of the Invention

[0016] According to the present invention, there are provided an IBA precursor compound that can continuously supply IBA by utilizing metabolism in a plant body, and a plant growth regulator comprising the same. [Brief description of the drawings]

[0017] [Figure 1] Figure 1 shows images of Arabidopsis rooting following the addition of JAX-91 or JAX-44. From left to right, the images are of no addition of these compounds, of 10 μM JAX-91, and of 10 μM JAX-44. [Diagram 2] Figure 2 shows images of the rooting state of tomatoes following the addition of JAX-91 or JAX-44. From the left, the images are of a plant without the addition of these compounds, a plant with the addition of 1 μM JAX-44, and a plant with the addition of 1 μM JAX-91. [Diagram 3] FIG. 3 is a graph showing the calculated numbers of lateral root primordia and lateral roots for each concentration when Arabidopsis thaliana was treated with 0 to 30 μM JAX-44. [Figure 4] FIG. 4 is a mass spectrometry chart of an Arabidopsis thaliana sample treated with an aqueous solution of JAX-44-d8. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0018] Hereinafter, an embodiment of the compound of the present invention, an embodiment of the plant growth regulator, and a first and second embodiments of the method for producing the compound will be described. Note that the present invention is not limited to the following embodiments and examples, and can be practiced with appropriate modifications within the scope of the present invention.

[0019] <Compound or its salt with an acidic compound> First, the compound of the present invention or a salt thereof with an acidic compound will be described. The compound of the present invention is represented by the following general formula (1). "Salt of this with an acidic compound" means a chemical species obtained by acting a strong acid on this compound to add a proton to the nitrogen atom of the indole ring represented by the following general formula (1). For example, when hydrochloric acid is acted on this compound, a proton is added to the nitrogen atom of the indole ring represented by the following general formula (1) to form a hydrochloride salt. Such a salt also has the same effect as the compound before it is made into a salt. Hereinafter, "the compound of the present invention or a salt thereof with an acidic compound" will be collectively referred to as "the compound of the present invention".

[0020] [ka]

[0021] In the above general formula (1), R 1 is an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms. Examples of such an alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, and a pentyl group. Examples of such an alkoxy group include a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, an isobutoxy group, a tert-butoxy group, and a pentoxy group. In the above general formula (1), R 1 When there are multiple R 1 are each independently selected.

[0022] A is -OR 2or -O - X + R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms. Examples of such an alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, and a pentyl group. Among these, a methyl group and an ethyl group are preferable. X + Li + , Na + , K + , NH4 + Or N + R 5 4. Each R 5 are each independently a hydrogen atom or an alkyl group having 5 or less carbon atoms. Examples of such an alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, and a pentyl group. - X + In this case, the compound, which is also a carboxylic acid compound, will be in the form of a carboxylic acid salt.

[0023] R 3 and R 4 R is a hydroxyl or amino group provided that one of them is a hydrogen atom, or together with the other, they form a (=O) group. 3 and R 4 When taken together to form a (=O) group, they will form a carbonyl group together with the carbon atom to which they are attached.

[0024] n is an integer of 0 to 4. When n is 1 to 4, which carbon atom of the indole ring is R 1 Indole-3-acetic acid (IAA) naturally contains indole-substituted derivatives such as 4-chloroindole-3-acetic acid, which act to regulate plant growth in the same way as IAA. In IBA, the indole-substituted derivatives also act to regulate plant growth in the same way as the indole-substituted derivatives in IAA.

[0025] When the compound of the present invention is transferred to a plant body, it is metabolized as shown in the following chemical formula, and is metabolized to the plant hormone IBA (indole-3-butyric acid) and its indole-substituted derivatives. That is, the compound of the present invention becomes a precursor of IBA and its indole-substituted derivatives. As a result, this compound acts as a plant hormone equivalent to IBA and its indole-substituted derivatives in the plant body, and exerts an action as a plant growth regulator, such as promoting the elongation of the lateral roots of the plant to which it is applied. Note that each of the starting compounds shown in the following chemical formulas is an example of the compound shown in the above general formula (1), and the present invention is not limited to each of the starting compounds shown below. In addition, the fact that the compound of the present invention undergoes such metabolism in the plant body to produce IBA has been verified by experiments conducted by the present inventors. Details of the experiment will be described in the Examples section of this specification.

[0026] [ka]

[0027] Specific examples of the compound of the present invention preferably include those represented by the following chemical formula. Indole-3-acetic acid (IAA) naturally contains indole-substituted derivatives such as 4-chloroindole-3-acetic acid, which regulate the growth of plants in the same way as IAA. The specific examples below also include precursors that are metabolized to indole-substituted derivatives of IBA, which also act to regulate the growth of plants in the same way as the indole-substituted derivatives of IAA.

[0028] [ka]

[0029] Among these specific examples, the two compounds represented by the following chemical formulas are particularly preferred: However, it goes without saying that the present invention is not limited to these specific examples.

[0030] [ka]

[0031] In addition, in the compound of the present invention, the α-position of a carboxy group or a carboxylate group, or the α-position of an alkoxycarbonyl group that is an alkyl ester of a carboxy group, is an asymmetric carbon. Therefore, the compound of the present invention can be made optically active by optical resolution, but the compound of the present invention may be a racemic body that is not subjected to optical resolution, or an optically active body that is subjected to optical resolution. Either case is included in the scope of the present invention.

[0032] <Plant growth regulator> As described above, the compound of the present invention is metabolized in the plant body to IBA (indole-3-butyric acid) and its indole-substituted derivatives. Therefore, like IBA and its indole-substituted derivatives, the compound of the present invention has activities such as growth effect, rooting promotion, cell elongation promotion, and cambium cell division induction in the plant body, as well as effects such as promoting the formation and elongation of lateral roots.

[0033] The method of applying the compound of the present invention to a plant body is the same as that used as a natural or synthetic auxin in the past as a pesticide or a chemical plant regulator. One example is adding the compound of the present invention to a nutrient solution for hydroponic cultivation of plants together with various nutrients. In this case, the preferred concentration of the compound of the present invention in the solution is preferably 0.1 μM to 30 μM, more preferably 0.1 μM to 10 μM or less. As is well known to those skilled in the art, the unit of "M" in "μM" etc. means "mol / L". The same applies hereinafter.

[0034] <First embodiment of the method for producing the compound of the present invention> The above-mentioned method for producing the compound of the present invention also constitutes one aspect of the present invention. Next, a first embodiment of the method for producing the compound of the present invention will be described. The production method of this embodiment is characterized by including the steps of sequentially carrying out the following steps (a) to (c). Each of these steps will be described.

[0035] In step (a), compounds represented by the following general formula (A) and (B) are cross-coupled to obtain a compound represented by the following general formula (C).

[0036] [ka]

[0037] The compound represented by the above general formula (A) is converted into an indole ring structure portion in the compound of the present invention represented by general formula (1). 1 are each independently an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms. Examples of such an alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, and a pentyl group. Examples of such an alkoxy group include a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, an isobutoxy group, a tert-butoxy group, and a pentoxy group. In the above general formula (A), R 1 When there are multiple R 1 are each independently selected. n is an integer of 0 to 4. When n is 1 to 4, R 1 may be combined.

[0038] X is a halogen atom. Preferred examples of such a halogen atom include a chlorine atom, a bromine atom, and an iodine atom, and among these, an iodine atom is more preferred.

[0039] R p is a hydrogen atom or a protecting group for the nitrogen of the indole ring. In the reactions in each step of the production method of the present invention, such a protecting group may be used to prevent the nitrogen of the indole ring from undergoing an unintended reaction and producing an unnecessary by-product. Such protecting groups are well known to those skilled in the art, and R in general formula (A) can be appropriately selected from various protecting groups. pExamples of such a protecting group include various protecting groups for amino groups, such as carbamate-based, amide-based, imide-based, and sulfonamide-based protecting groups. Among these, carbamate-based protecting groups are preferred, and examples thereof include tert-butoxycarbonyl (Boc) group, benzyloxycarbonyl (Cbz) group, 9-fluorenylmethyloxycarbonyl (Fmoc) group, 2,2,2-trichloroethoxycarbonyl (Troc) group, allyloxycarbonyl (Alloc), methoxycarbonyl group, and ethoxycarbonyl group.

[0040] [ka]

[0041] The compound represented by the above general formula (B) is a precursor of the pentanoic acid skeleton in the compound of the present invention represented by general formula (1). 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms. Examples of such an alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, and a pentyl group, and among these, a methyl group and an ethyl group are preferable.

[0042] R 3p is a hydroxyl group or an amino group which may have a protecting group. The term "hydroxyl group or amino group which may have a protecting group" refers to a hydroxyl group, an amino group, a hydroxyl group having a protecting group, or an amino group having a protecting group.

[0043] Protective groups for hydroxyl and amino groups are well known to those skilled in the art. Such protective groups are appropriately selected and bonded to hydroxyl or amino groups to form R 3pExamples of the protective group for the hydroxyl group include ether-based, acetal-based, acyl-based, and silyl ether-based protective groups. Among these, silyl ether-based protective groups are preferred, and an example thereof is tert-butyldimethylsilyl. Examples of the protective group for the amino group include various protective groups such as carbamate-based, amide-based, imide-based, and sulfonamide-based. Among these, carbamate-based protective groups are preferred, and examples thereof are tert-butoxycarbonyl (Boc) group, benzyloxycarbonyl (Cbz) group, 9-fluorenylmethyloxycarbonyl (Fmoc) group, 2,2,2-trichloroethoxycarbonyl (Troc) group, allyloxycarbonyl (Alloc), methoxycarbonyl group, and ethoxycarbonyl group.

[0044] [ka]

[0045] The compound represented by the above general formula (C) can be obtained by cross-coupling the compound represented by the general formula (A) and the compound represented by the general formula (B). This cross-coupling reaction is called the Sonogashira-Hagiwara cross-coupling reaction and is well known to those skilled in the art, so this cross-coupling reaction can be carried out under appropriate conditions. One example of such conditions is to react the compound represented by the general formula (A) and the compound represented by the general formula (B) by heating in the presence of a palladium catalyst, copper (I) iodide, and an amine compound. Examples of the palladium catalyst include Pd(0) complex compounds such as tetrakis(triphenylphosphine)palladium, and Pd(II) complexes such as dichlorobis(triphenylphosphine)palladium. In addition, when a Pd(II) complex is used as a catalyst, it may be used in combination with a phosphine compound such as triphenylphosphine. As an amine compound, triethylamine is preferably used. Of course, the conditions of the cross-coupling reaction are not limited to these.

[0046] R in general formula (C) 1 , R p and n are the same as those in the above general formula (A). 2 and R 3p is the same as in the above general formula (B).

[0047] In step (b), the compound represented by the above general formula (C) is reduced to obtain a compound represented by the following general formula (D). Through this step, the triple bond in general formula (C) is reduced to a single bond, resulting in a pentanoic acid skeleton.

[0048] [ka]

[0049] To reduce the compound represented by the above general formula (C), a reduction reaction well known to those skilled in the art may be appropriately selected and carried out. An example of such a reduction reaction is a reaction in which palladium carbon (also expressed as palladium-activated carbon; Pd / C) is added to a solution containing the compound represented by the general formula (C) and the solution is stirred under a hydrogen atmosphere.

[0050] R in the above general formula (D) 1 , R p and n are the same as those in the above general formula (A). 2 and R 3p is the same as in the above general formula (B).

[0051] Step (c) is a step of reacting a compound represented by the above general formula (D) with R p is a hydrogen atom, and R 3pIn the case where the hydroxyl group or amino group represented by the formula (A) does not have a protecting group, this step is not performed, and in other cases, the compound represented by the formula (D) is deprotected to obtain the compound represented by the formula (E) below. In the step (c), when the compound represented by the formula (D) has a protecting group, the protecting group is removed to obtain the target compound represented by the formula (E). In addition, when the compound represented by the formula (D) does not have a protecting group, the compound itself is already a compound represented by the formula (E), so there is no need to perform the step (c). In addition, the compound represented by the formula (E) corresponds to the compound of the present invention represented by the formula (1) above.

[0052] [ka]

[0053] To deprotect the compound represented by general formula (D), a deprotection reaction may be selected according to the protecting group applied to the compound. Such deprotection reactions are well known to those skilled in the art. For example, if a carbamate-based protecting group such as Boc or a methoxycarbonyl group is applied to the compound, the compound may be deprotected by treating with an acid or base.

[0054] In the above general formula (E), R 1 , R 2 and n are the same as those in the above general formulas (A) and (B). 3 is a hydroxyl group or an amino group.

[0055] <Second embodiment of the method for producing the compound of the present invention> Next, a second embodiment of the method for producing the compound of the present invention will be described. The method for producing the compound of this embodiment is characterized by comprising the steps of carrying out the following steps (d) to (f) in order. Each of these steps will be described.

[0056] In step (d), a compound represented by the following general formula (F) is reduced to obtain a compound represented by the following general formula (G).

[0057] [ka]

[0058] In the above general formula (F), each R 1 are each independently an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms. Examples of such an alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, and a pentyl group. Examples of such an alkoxy group include a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, an isobutoxy group, a tert-butoxy group, and a pentoxy group. In the above general formula (F), R 1 When there are multiple R 1 are each independently selected. n is an integer of 0 to 4. When n is 1 to 4, R 1 may be combined.

[0059] R 6 is a hydrogen atom or an alkyl group having a carbon number of 1 to 5. Examples of such an alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, and a pentyl group.

[0060] R p is a protecting group for the nitrogen atom of the indole ring. Such protecting groups are the same as those described above for the formula (A), and therefore will not be described here.

[0061] [ka]

[0062] R in the above general formula (G) 1 , R p and n are the same as those in the above general formula (F).

[0063] The carboxylic acid or its alkyl ester represented by the above general formula (F) is converted to an aldehyde represented by the general formula (G) by reduction. In order to reduce the compound represented by the above general formula (F), a reduction reaction well known to those skilled in the art may be appropriately selected and carried out. As an example of such a reduction reaction, a reduction reaction may be carried out by reacting a compound represented by the general formula (F) with a hydride (H - A preferred example is the reaction of a compound which generates a hydride. Examples of the compound which generates a hydride include sodium hydride, calcium hydride, diisobutylaluminum hydride (DIBAL), lithium aluminum hydride, and tributyltin hydride. Since the means for carrying out a reduction reaction using these compounds are well known to those skilled in the art, this step may be carried out by appropriately selecting such a well-known means.

[0064] In step (e), a compound represented by the above general formula (G) is reacted with a cyanide anion to obtain a compound represented by the following general formula (H).

[0065] [ka]

[0066] In general formula (H), R 1 , R p and n are the same as those in the above general formula (F).

[0067] In this process, the cyanide anion (CN - ) attacks the carbonyl group of the compound represented by general formula (G), bonding a cyano group to the carbon atom of the carbonyl group and converting the oxygen atom of the carbonyl group into a hydroxyl group.

[0068] Examples of compounds that generate cyanide anions include various cyanide salt compounds such as potassium cyanide, sodium cyanide, etc. By adding such compounds to a reaction solution containing a compound represented by general formula (G), a predetermined chemical reaction occurs in this step.

[0069] In step (f), the compound represented by the above general formula (H) is reacted with an acid or base in the presence or absence of an alcohol having 1 to 5 carbon atoms to hydrolyze the cyano group present in the compound, thereby obtaining a compound represented by the following general formula (I). Note that, in this step, the action of an acid or base causes the above hydrolysis and also removes the protecting group R bonded to the nitrogen of the indole ring. p The compound represented by the general formula (I) corresponds to the compound of the present invention represented by the above general formula (1).

[0070] [ka]

[0071] In the above general formula (I), R 1 and n are the same as those in the above general formula (F). 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms. Examples of such an alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, and a pentyl group, and among these, a methyl group and an ethyl group are preferable.

[0072] In this step, an acid or a base is used to carry out the hydrolysis. Examples of such acids include concentrated hydrochloric acid, sulfuric acid, nitric acid, and trifluoroacetic acid. Examples of such bases include sodium hydroxide and potassium hydroxide. In addition, when carrying out the hydrolysis reaction, a chlorosilane compound such as trimethylsilyl chloride may be coexisted. Such compounds generate hydrogen chloride (hydrochloric acid) as an acid by being decomposed in the reaction system, and at that time, become Me3SiOSiMe3 or the like, and have the effect of removing moisture from the reaction system. As described above, since the chlorosilane compound generates hydrogen chloride (hydrochloric acid) in the reaction system, the chlorosilane compound may be used instead of the acid in step (f) or together with the acid. Even when a chlorosilane compound is used instead of an acid, hydrogen chloride (hydrochloric acid) is generated as described above, so the reaction system is still "acted with an acid."

[0073] The phrase "in the presence or absence of an alcohol having 1 to 5 carbon atoms" means that such an alcohol may be added optionally when carrying out the reaction in this step. When such an alcohol is added, R 2 In the absence of an alcohol, an ester having R 2 A carboxylic acid in which is a hydrogen atom can be obtained. EXAMPLES

[0074] The present invention will be described in more detail below by showing examples, but the present invention is not limited to the following examples in any way.

[0075] Synthesis of methyl 2-hydroxy-5-(1H-indol-3-yl)pentanoate (JAX-44) and 2-hydroxy-indol-3-yl)pentanoic acid (JAX-77) [ka]

[0076] Under an argon atmosphere, diisobutylaluminum hydride (DIBAL, 1.0 M toluene solution, 4.88 mL, 4.88 mmol) was added dropwise to a solution of tert-butyl-3-(4-methoxy-4-oxobutyl)-1H-indole-1-carboxylate (1.41 g, 4.44 mmol) in toluene (63 mL) at -78 °C. After stirring at -78 °C for 2 hours, 1 M hydrochloric acid (30 mL) was added. The mixture was extracted with ethyl acetate (3 × 30 mL), and the organic layer was washed with saturated saline. After drying over anhydrous sodium sulfate and filtration, the filtrate was concentrated under reduced pressure. The obtained crude product of tert-butyl-3-(4-oxobutyl)-1H-indole-1-carboxylate was used as it was in the next reaction.

[0077] To a solution of the crude product of tert-butyl-3-(4-oxobutyl)-1H-indole-1-carboxylate in methylene chloride (6.5 mL) at room temperature, an aqueous solution of potassium cyanide (4.7 M, 6.4 mL, 30.1 mmol) was added, followed by the addition of acetic acid (1.73 mL, 30.2 mmol). After stirring at room temperature for 15 hours, water (30 mL) was added for dilution. The mixture was extracted with methylene chloride (3 x 30 mL), and the organic layer was washed with saturated saline. After drying over anhydrous sodium sulfate and filtration, the filtrate was concentrated under reduced pressure. The obtained crude product of tert-butyl-3-(4-cyano-4-hydroxybutyl)-1H-indole-1-carboxylate was used as it was in the next reaction.

[0078] Trimethylsilyl chloride (2.8 mL, 22.2 mmol) was added to a mixture of the crude product of tert-butyl-3-(4-cyano-4-hydroxybutyl)-1H-indole-1-carboxylate in methanol (9.0 mL) and methylene chloride (4.5 mL) at 0°C under an argon atmosphere, followed by concentrated hydrochloric acid (0.75 mL, 8.9 mmol). After stirring at room temperature for 22 hours, 1M aqueous sodium hydroxide solution (70 mL) was added. The mixture was extracted with ethyl acetate (3 x 30 mL), and the organic layer was washed with saturated saline. After drying over anhydrous sodium sulfate and filtration, the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate = 4:1 to 1:1), and methyl-2-hydroxy-5-(1H-indol-3-yl)pentanoate (JAX-44; 297.4 mg) was obtained in a total yield of 28% over four steps.

[0079] In addition, 1M hydrochloric acid was added to the aqueous phase obtained above to adjust the pH to 3, and then the aqueous phase was extracted with ethyl acetate (3 x 30 mL). The organic layer was washed with saturated saline and dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure to give 2-hydroxy-5-(1H-indol-3-yl)pentanoic acid (JAX-77; 532 mg) in a total yield of 51% over the four steps.

[0080] Methyl-2-hydroxy-5-(1H-indol-3-yl)pentanoate (JAX-44) 1 H-NMR(500MHz,CDCl3):δ(ppm) 7.96(brs,1H,NH),7.59(d,J=8.0Hz,1H,Ar),7.33(d,J=8.0Hz,1H,Ar),7.18(m,1H,Ar),7.10(m,1H,Ar),6.95(s,1H,Ar),4 3(m,1H,CHO), 3.74(s,3H,CO2CH3), 2.84-2.74(m,2H,ArCH2 of CH2), 2.79(m,1H,OH), 1.93-1.78(m,3H,CH2), 1.74(m,1H,CH2). 13 C-NMR(125MHz,CDCl3):δ(ppm) 175.7,136.3,127.4,121.8,121.2,119.1,118.8,116.0,111.0,70.4,52.4,34.1,25.2,24.7. IR(cm) -1 ): 3409,2950,1727,1456,1222,1096,1009,740. HRMS(TOF) m / z [M+Na] + calcd.for[C 14 H 17 N1NaO3] + 270.1106,found270.1113.

[0081] 2-Auto-5-(1H-Auto-3-Auto)Cluster(JAX-77) 1 H-NMR(600MHz,DMSO-d6):δ(ppm) 10.7(s,1H,COOH),7.49(m,1H,Ar),7.32(d,J=8.4Hz,1H,Ar),7.08(d,J=1.8Hz,1H,Ar),7.05(m,1H,Ar); ,6.95(m,1H,Ar),3.97(m,1H,CHO),2.73-2.63(2H,Ar-CH2 of CH2),1.76-1.66(3H,CH2),1.59(m,1H,CH2), 13CNMR(150MHz,DMSO-d6):δ(ppm) 175.9,136.3,127.2,122.1,120.8,118.3,118.0,114.4,111.3,69.6,33.9,25.7,24.4. FT-IR (neat, cm -1 ): 3384,1708,1455,1256,1103,1009,913,737.

[0082] Synthesis of 1-(methoxycarbonyl)-5-nitro-3-iodoindole [ka]

[0083] Under an argon atmosphere, crushed potassium hydroxide (1.73 g, 30.8 mmol) was added to a solution of 5-nitroindole (1.99 g, 12.19 mmol) in dehydrated dimethylformamide (DMF; 20 mL) at room temperature. After stirring at the same temperature for 30 minutes, a solution of iodine (3.12 g, 12.2 mmol) in dehydrated DMF (3.7 mL) was added to the reaction mixture. The reaction mixture was stirred at room temperature for 6 hours, and ice water (230 mL) containing ammonium hydroxide (0.5%) and sodium sulfite (0.1%) was added. The mixture was extracted with a 1:1 mixture of n-hexane and ethyl acetate (3 x 150 mL), and the organic phase was washed with cold water (150 mL). After drying over anhydrous sodium sulfate and filtration, the filtrate was concentrated under reduced pressure to obtain 5-nitro-3-iodoindole as a yellow solid.

[0084] Triethylamine (4.8 mL, 35.7 mmol) and methyl chloroformate (2.76 mL, 35.7 mmol) were added to a solution of 5-nitro-3-iodoindole (3.44 g, 11.9 mmol) in dichloromethane (DCM; 75 mL) at 0° C. under an argon atmosphere. The reaction mixture was stirred at 0° C. for 10 minutes, then at room temperature for 25 minutes, and water (20 mL) was added to quench the reaction. The mixture was extracted with DCM (3×50 mL), and the organic phase was washed with water (30 mL) and then with saturated saline (30 mL), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel flash column chromatography (hexane:ethyl acetate=1:1) to obtain 1-(methoxycarbonyl)-5-nitro-3-iodoindole (3.40 g, 81% yield) as a pink solid.

[0085] 1 H-NMR(500MHz,CDCl3)δ(ppm) 8.36(m,1H,Ar),8.30(m,2H,Ar),7.91(s,1H,Ar),4.11(s,3H,COOCH3).

[0086] Synthesis of JAX-89 [ka]

[0087] Under an argon atmosphere, a solution of 1-(methoxycarbonyl)-5-nitro-3-iodoindole (0.53 g, 1.53 mmol), dichlorobis(triphenylphosphine)palladium(II) (5.5 mg, 0.00784 mmol) and copper(I) iodide (0.9 mg, 0.00473 mmol) in DMF (0.8 mL) was added with triethylamine (7.9 mL) at 50°C, and a solution of 2-hydroxy-4-pentynoic acid ethyl (0.312 g, 2.19 mmol) in diethyl ether (1.3 mL) was added. The reaction mixture was stirred at the same temperature for 4 hours, and then 1N aqueous hydrochloric acid solution was added to the reaction mixture at 0°C to stop the reaction. The mixture was extracted with diethyl ether (5 x 20 mL), and the organic phase was washed with saturated saline. This was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. Under an argon atmosphere, potassium carbonate (0.55 g, 3.98 mmol) was added to a solution of the crude product mixture (0.61 g, 1.68 mmol) in dehydrated ethanol (20 mL) while stirring at room temperature. The reaction mixture was then stirred at room temperature for 5 hours and 35 minutes, and an aqueous solution of ammonium chloride was added to the reaction mixture to quench the reaction. The mixture was extracted with diethyl ether (3 x 10 mL), and the organic phase was washed with saturated saline. After drying over anhydrous sodium sulfate and filtration, the filtrate was concentrated under reduced pressure. The residue was purified by silica gel flash column chromatography (hexane:ethyl acetate = 3:1) to obtain JAX-89 (0.33 g, 71% yield) as a yellow oil.

[0088] 1 H-NMR (500MHz, CDCl3) δ(ppm) 8.63(s,1H,NH),8.62(d,J=1.5Hz,1H,Ar),8.13(dd,J=2.0,9.0Hz,1H,Ar),7.47 (d,J=2.0Hz,1H,Ar),7.41(d,J=9.5Hz,1H,Ar),4.47(q,J=3.0Hz,1H,CHOC),4.38 (m,2H,OCH2),3.22(d,J=7.0Hz,1H,OH),3.05(dd,J=5.0,17.0Hz,1H,Ar-CC-CH2 CH2),3.00(dd,J=5.0,16.5Hz,1H,CH2 of Ar-CC-CH2),1.37(t,J=7.3Hz,3H,CH3). 13 C-NMR(125MHz,CDCl3)δ(ppm) 173.4,142.3,137.9,130.6,128.1,118.4,117.0,111.5,101.0,86.9,74.8,69.2,62.4,26.1,14.3. FT-IR (neat, cm -1 ): 3330,1733,1541,1335.

[0089] Synthesis of JAX-90 and JAX-91 [ka]

[0090] A solution of JAX-89 (0.139 g, 0.46 mmol) and Pd / C (10% by mass, 18.7 mg) in dehydrated ethanol (4.6 mL) was stirred for 22 hours at room temperature under a hydrogen atmosphere. The reaction mixture was then filtered twice through Celite, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel flash column chromatography (hexane:ethyl acetate=1:1) to obtain JAX-90 (0.0798 g, yield 57%) as a yellow oil and JAX-91 (0.042 g, yield 33%) as a brown oil. Note that "Celite" is Celite (registered trademark) from Imerys Filtration Minerals (hereinafter the same).

[0091] Ethyl-2-hydroxy-5-(1H-5-nitroindol-3-yl)pentanoate (JAX-90) 1 H-NMR(500MHz,CDCl3)δ(ppm) 8.57(d,J=2.0Hz,1H,Ar),8.37(dd,J=2.0Hz,9.0Hz,1H,Ar),7.38(d,J=9.0Hz,1H,Ar),7.15(d,J=2.5Hz,1 H,Ar),4.24(m,3H,OCH2,CHO),2.84(m,3H,CH2,OH of Ar-CH2),1.84(m,4H,CH2),1.28(t,J=7.0Hz,3H,CH3). 13C-NMR(125MHz,CDCl3)δ(ppm) 175.1,141.1,139.3,126.8,124.5,118.6,117.4,116.1,111.1,70.2,61.6,34.0,25.5,24.5,14.1.

[0092] Ethyl-2-hydroxy-5-(1H-5-aminoindol-3-yl)pentanoate (JAX-91) 1 H-NMR(500MHz,CDCl3)δ(ppm) 7.75(s,1H,Ar),7.15(d,J=8.5Hz,1H,Ar),6.90(dd,J=2.3,10.8Hz,2H,Ar),6.65(dd,J=2.5,8.5Hz,1 H,Ar),4.21(m,3H,OCH2,CHO),2.71(m,3H,-ArCH2,OH),1.80(m,4H,CH2),1.26(t,J=7.5Hz,3H,CH3). 13 C-NMR(125MHz,CDCl3)δ(ppm) 175.2,138.8,131.2,128.3,121.9,115.0,112.8,111.6,104.0,70.4,61.5,34.2,25.0,24.8,14.1. FT-IR (neat, cm -1 ): 3332,2979,2934,2862,1731,1459.

[0093] [Activity test (Arabidopsis thaliana)] After sterilizing 1 / 2 Murashige-Skoog (1 / 2 MS) medium (1% sucrose, 0.8% agar, pH 5.8 ± 0.05) under high temperature and high pressure conditions, a dimethyl sulfoxide (DMSO) solution of the test compound was added to the medium to the desired concentration. It has been confirmed that a DMSO concentration of 0.1% or less in the medium does not affect plant growth. Non-genetically modified Arabidopsis seeds were sterilized with a 10% sodium hypochlorite solution for 10 minutes and washed five times. The medium in this test was made on a plastic plate, and 17 seeds were planted on the top of each plate. The plants were exposed to low winter temperatures at 4°C for 1-4 days to induce germination, and then the plates were stood up and covered with aluminum foil below the part where the seeds were planted, and grown for 8 days at 22°C under continuous light irradiation. This test was carried out with 10 μM JAX-91 added as a test compound, with 10 μM JAX-44 added as a test compound, and without adding these compounds as a control.

[0094] Figure 1 shows a photograph of the rooting state 8 days after the start of this test. Figure 1 shows images of Arabidopsis rooting state following the addition of JAX-91 or JAX-44, with images from the left showing no addition of these compounds, addition of 10 μM JAX-91, and addition of 10 μM JAX-44. As shown in Figure 1, it was confirmed that more lateral roots were generated in the cases where JAX-91 or JAX-44 was added than in the cases where these compounds were not added.

[0095] [Activity test (tomato)] The medium was prepared after sterilizing 1 / 2MS medium (1% sucrose, 0.8% agar, pH 5.8±0.05) under high temperature and high pressure conditions. Non-genetically modified tomato seeds were sterilized with 10% sodium hypochlorite aqueous solution for 5 minutes and washed 5 times. The medium in this test was prepared on a plastic plate. Six seeds were planted on the top of each medium. After leaving the plate at 4°C for 1-4 days, the plate was stood up and covered with aluminum foil below the part where the seeds were planted, and the plates were grown for 5 days at 25°C under continuous light conditions. The tomatoes grown for 5 days were transferred to water and grown hydroponically. In this hydroponic cultivation, a DMSO solution of the test compound was added to the water for hydroponic cultivation so that the water contained the test compound at a specified concentration. This hydroponic cultivation was carried out at 25°C under continuous light irradiation conditions for 5 days. This test was carried out with the addition of 1 μM JAX-91 as a test compound, with the addition of 1 μM JAX-44 as a test compound, and without the addition of these compounds as a control.

[0096] Figure 2 shows a photograph of the rooting state on the fifth day after the start of hydroponic cultivation. Figure 2 shows images of the rooting state of tomatoes with the addition of JAX-91 or JAX-44, with images from the left showing no addition of these compounds, an image with 1 μM JAX-44 added, and an image with 1 μM JAX-91 added. As shown in Figure 2, it was confirmed that the number of hairy roots was significantly increased in the cases where JAX-91 or JAX-44 was added compared to the cases where these compounds were not added.

[0097] [Microscopic observation of JAX-44-treated Arabidopsis thaliana] Arabidopsis thaliana was grown for 4 days on agar medium containing JAX-44 at concentrations of 0 to 30 μM, after which the Arabidopsis was fixed and made transparent, and the lateral root primordia were observed under a differential interference microscope. First, 1 / 2MS medium (1% sucrose, 0.8% agar, pH 5.8 ± 0.05) was sterilized under high temperature and high pressure conditions, and a dimethyl sulfoxide (DMSO) solution of JAX-44 was added to the medium to the desired concentration. Non-modified Arabidopsis thaliana seeds were sterilized with a 10% sodium hypochlorite solution for 10 minutes and washed five times with sterile distilled water. The medium in this test was prepared on a plastic plate. Seventeen seeds were planted on the top of each medium. After vernalization treatment at 4°C for 1-4 days, the plate was stood up and grown for 4 days under continuous light irradiation at 22°C with the area below the seed-planted part covered with aluminum foil. The Arabidopsis thus grown was placed in a 4% (w / v) paraformaldehyde solution as a fixative, and the pressure was reduced in a desiccator using a vacuum pump and left at room temperature for 30 minutes. After 30 minutes, the pressure was reduced again and the desiccator was left at room temperature for another 30 minutes to fix the Arabidopsis. The fixative was then removed, 1x phosphate buffered saline (PBS) was added, and the desiccator was left at room temperature for 1 minute. The Arabidopsis was washed by removing the 1x PBS, adding fresh 1x PBS, and leaving the desiccator at room temperature for 1 minute twice. The 1x PBS was removed, and a plant tissue clearing reagent (manufactured by Fujifilm Wako Pure Chemical Industries, product name ClearSee) was added, and the pressure was reduced using a vacuum pump. The desiccator was left at room temperature for 30 minutes, and the pressure was reduced again and left at room temperature for another 30 minutes. The pressure was then returned to atmospheric pressure, and the dehumidified desiccator was left at room temperature for 7 days. The Arabidopsis thus fixed and cleared was observed under a differential interference microscope, and the number of lateral root primordia and lateral roots for each concentration was calculated and graphed. The results are shown in Figure 3. As shown in FIG. 3, when JAX-44 was used, a significant increase in the number of lateral root primordia and the number of lateral roots was observed in the range of 3 to 10 μM.

[0098] Synthesis of deuterated JAX-44 (JAX-44-d8) [ka]

[0099] JAX-77 (46.7 mg, 0.20 mmol) was dissolved in deuterated methanol (CD3OD, 2.5 mL) containing 20% ​​by mass of bisulfuric acid (D2SO4) to obtain a solution, which was then stirred at 60°C for 15 hours. The reaction mixture was then slowly poured into saturated aqueous sodium bicarbonate (20 mL). The mixture was extracted with diethyl ether (3 x 10 mL), and the organic phase was washed with saturated saline and dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure and purified by silica gel column chromatography (ethyl acetate:hexane = 1:2) to obtain JAX-44-d8 (37.6 mg, 74% yield). The deuteration rate at C2 and C4-C7 carbons of the imidazole ring was 97% on average.

[0100] [Tracking of JAX-44 metabolites] JAX-44-d8 synthesized by the above procedure was used to track the metabolites of JAX-44 in plants. First, non-genetically modified Arabidopsis seeds were sterilized with 10% hypochlorite for 10 minutes and washed five times with sterile distilled water. After washing, the supernatant distilled water was removed, 0.1% agar was added, and the seeds were dispersed by pipetting. Approximately 250 of these sterilized seeds were planted on a 1 / 2 MS medium plate. The plate was subjected to a vernalization treatment at 4°C for half a day to four days to induce germination, and then the seeds were placed in an artificial weather chamber (TOMY, CLE-405, illuminance 42.93 μmol m 2 ) at 22°C and a 24-hour light period. -2 ·s -1 ) for 6 days. After cultivation, 50mL tubes containing 10mL of sterile distilled water were prepared, and about 20 Arabidopsis plants were transferred from the medium to each tube and cultured with shaking for 24 hours. A 0.1% DMSO solution of JAX-44-d8 was prepared, and Arabidopsis plants were immersed in 10mL of water to which 10μL of this DMSO solution was added for 3 hours. After that, the Arabidopsis plants were collected and thoroughly dried, and then placed in a 2mL Eppendorf tube containing 5mm stainless steel beads for crushing plant bodies and weighed. After that, they were quickly frozen using liquid nitrogen, and the Arabidopsis samples were crushed twice per sample using a QIAGEN TissueLyser LT at settings of 45times / sec and 25sec.

[0101] 1 mL of diethyl ether was added to the Eppendorf tube containing the Arabidopsis thaliana sample and stirred with a vortex for about 30 seconds. The tube was left to stand in the refrigerator for 16 hours. After removing it from the refrigerator, the supernatant was collected with a pipette and filtered through a cotton funnel. Another 1 mL of diethyl ether was added to the Eppendorf tube containing the plant sample, and the supernatant was collected and filtered. This supernatant was then concentrated under reduced pressure. The concentrated sample was dissolved in methanol, filtered through a membrane filter, and concentrated again. This state was subjected to mass spectrometry. The results are shown in Figure 4. Figure 4 shows a mass spectrometry chart of an Arabidopsis thaliana sample treated with an aqueous solution of JAX-44-d8.

[0102] As shown in Figure 4, in the mass spectrometry chart, the peak of JAX-77-d5 (hydrolysate of JAX-44-d8), a metabolite of JAX-44-d8, was observed at m / z 273, and the peak of d5-IBA, which is further metabolized to IBA, was observed at m / z 207. It is clear that these deuterated JAX-77-d5 and d5-IBA are derived from deuterated JAX-44-d8, and it was confirmed that the compound of the present invention produces IBA by being metabolized in the plant body.

[0103] Synthesis of ethyl 2-hydroxy-5-(1-tert-butoxycarbonyl indol-3-yl) pent-4-ynoate [ka]

[0104] Under an argon atmosphere, a solution of 1-(tert-butoxycarbonyl)-3-iodoindole (0.310 g, 0.904 mmol), dichlorobis(triphenylphosphine)palladium(II) (25.4 mg, 0.036 mmol), copper(I) iodide (6.9 mg, 0.0362 mmol) and triphenylphosphine (18.7 mg, 0.0723 mmol) in tetrahydrofuran (THF, 1.0 mL) was added with triethylamine (0.63 mL, 4.51 mmol) at room temperature, and a solution of ethyl 2-hydroxy-4-pentynoate (1.129 g, 0.904 mmol) in THF (1.3 mL) was added. The reaction mixture was stirred at 50° C. for 42 hours, and then a saturated aqueous solution of ammonium chloride was added to the reaction mixture to quench the reaction. The mixture was extracted with ethyl acetate, and the organic phase was washed with saturated saline. This was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (chloroform) to obtain ethyl 2-hydroxy-5-(1-tert-butoxycarbonylindol-3-yl)pent-4-ynoate (0.228 g, yield 70%) as a yellow oil. HRMS(TOF) m / z [M+Na] + calcd. for [C 20 H 23 N1NaO5] + 380.1474,found 380.1483.

[0105] Synthesis of JAX-49 [ka]

[0106] A suspension of ethyl-2-hydroxy-5-(1-tert-butoxycarbonylindol-3-yl)pent-4-ynoate (0.913 g, 2.55 mmol) and Pd(OH)2 / C (10% by mass, 91.3 mg) in ethanol (25.5 mL) was stirred for 22 hours under hydrogen atmosphere at room temperature. The reaction mixture was then filtered through Celite, and the filtrate was concentrated under reduced pressure. Concentrated hydrochloric acid (1.35 mL, 16.1 mmol) was added to a solution of this crude product in ethyl acetate (26.9 mL), and the mixture was stirred at room temperature for 2 hours. A saturated aqueous solution of sodium bicarbonate was added to the reaction mixture to stop the reaction, and the mixture was extracted with ethyl acetate. The organic phase was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (chloroform:ethyl acetate=15:1) to obtain JAX-49 (91.8 mg, 13% yield) as a brown oil.

[0107] 1 H-NMR(600MHz,CDCl3):δ(ppm) 7.95(brs,1H,NH),7.60(d,J=8.4Hz,1H,Ar),7.35(d,J=7.8Hz,1H,Ar),7.19(m,1H,Ar),7.11(m,1H,Ar),6.98(m,1H,Ar),4.27-4.18( 3H,OCH2,CHO),3.04-2.60(3H,Ar-CH2CH2,OH),1.95-1.86(2H,CH2),1.84(m,1H,CH2),1.75(m,1H,CH2),1.26(t,J=7.2Hz,3H,CH3). 13 C-NMR (150MHz, CDCl3): δ(ppm) 175.3,136.3,127.5,121.9,121.2,119.1,118.9,116.2,111.0,70.4,61.6,34.2,25.1,24.8,14.2. FT-IR (neat, cm -1 ): 3413,1731,1457,1099,1019,741.

[0108] Synthesis of tert-butyl 3-(4-((tert-butoxycarbonyl)amino)-5-ethoxy-5-oxopent-1-yn-1-yl)-1H-indole-1-carboxylate [ka]

[0109] At -4°C, ground potassium hydroxide (0.33 g, 5.9 mmol) was added to a solution of 2-((diphenylmethylene)amino)acetic acid ethyl ester (1.0 g, 3.7 mmol), tetrabutylammonium bromide (TBAB, 0.12 g, 0.37 mmol), and 3-bromoprop-1-yne (0.45 mL) in toluene (3.1 mL). The reaction mixture was stirred at the same temperature for 2 hours and 30 minutes to obtain ethyl 2-((diphenylmethylene)amino)pent-4-ynoate. At 2°C, 6N hydrochloric acid was added to the mixture until the pH was 2. The reaction mixture was allowed to warm to room temperature and stirred for 6 days. Ethanol (3.0 mL) was added to the reaction mixture and the stirring was continued for 4 hours, after which the organic solvent was removed under reduced pressure. 6N aqueous sodium hydroxide was added to the resulting mixture until the pH was 10, and di-tert-butyl dicarbonate (Boc2O, 3.6 mL, 16 mmol) was added. After reacting at room temperature for 5 days, the mixture was extracted with diethyl ether (50 mL x 3), and the organic phase was treated with 6N aqueous sodium hydroxide until the pH reached 10. The organic phase was washed with saturated aqueous sodium chloride and then dried over anhydrous sodium sulfate. The organic phase was filtered and concentrated under reduced pressure to obtain ethyl 2-((tert-butoxycarbonyl)amino)pent-4-ynoate (0.55 g, yield 62%) as a yellow oil.

[0110] A solution of 3-iodo-1H-indole-1-carboxylate 13 (0.11 g, 0.29 mmol), dichlorobis(triphenylphosphine)palladium(II) (12 mg, 0.017 mmol) and copper(I) iodide (2.2 mg, 0.012 mmol) in DMF (0.8 mL) was added with triethylamine (1.5 mL) at 50°C under an argon atmosphere, and a solution of ethyl 2-((tert-butoxycarbonyl)amino)pent-4-ynoate (0.085 g, 0.35 mmol) in diethyl ether (0.3 mL) was added. The reaction mixture was stirred at the same temperature for 24 hours, and then 1N aqueous hydrochloric acid was added to the reaction mixture at 0°C until the pH reached 1 to quench the reaction. The mixture was extracted with diethyl ether (3 x 20 mL), and the organic phase was washed with saturated saline. This was dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate=3:1) to give a yellow solid, tert-butyl 3-(4-((tert-butoxycarbonyl)amino)-5-ethoxy-5-oxopent-1-yn-1-yl)-1H-indole-1-carboxylate (0.11 g, yield 75%).

[0111] 1 H-NMR(400MHz, CDCl3):δ(ppm) 8.12(d,J=8.0Hz,1H,Ar),7.69(s,1H,Ar),7.62(d,J=8.0Hz,1H,Ar),7.34(t,J=7.6Hz,1H,Ar),7.28(t,J=7.6Hz,1H,Ar),5.46(m,1H,CHCN),4. 54-4.58(1H,CNH),4.20-4.33(2H,OCH2),2.98-3.09(2H,CC-CH2),1.66(s,9H,N-Boc),1.46(s,9H,NHBoc),1.29(t,J=6.8Hz,3H,CH3 of OCH2CH3).

[0112] Synthesis of .JAX-106 [ka]

[0113] Under a hydrogen atmosphere, a suspension of tert-butyl 3-(4-((tert-butoxycarbonyl)amino)-5-ethoxy-5-oxopent-1-yn-1-yl)-1H-indole-1-carboxylate (0.086 g, 0.19 mmol) and Pd / C (10 mass%, 18 mg) in dehydrated ethanol (1.9 mL) was stirred at room temperature for 6 days. Thereafter, the reaction mixture was filtered through Celite, and the filtrate was concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (hexane:ethyl acetate=5:1) to obtain yellow oily tert-butyl 3-(4-((tert-butoxycarbonyl)amino)-5-ethoxy-5-oxopentyl)-1H-indole-1-carboxylate (0.055 g, yield 63%).

[0114] A solution of tert-butyl 3-(4-((tert-butoxycarbonyl)amino)-5-ethoxy-5-oxopentyl)-1H-indole-1-carboxylate (9.3 mg, 0.020 mmol), trifluoroacetic acid (TFA, 0.22 mL) and methylene chloride (0.22 mL) was stirred at room temperature for 1 hour, and the reaction mixture was concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (chloroform:methanol=15:1) to give JAX-106 (3.6 mg, 69% yield) as a brown oil.

[0115] 1 H-NMR(400MHz, CDCl3):δ(ppm) 7.99(brs,1H,-NH),7.56(d,J=8.0Hz,1H,Ar),7.32(d,J=8.0Hz,1H,Ar),7.17(t,J=7.2Hz,1H,Ar),7.09(t,J=7.2Hz,1H,A r),6.98(s,1H,Ar),4.14(q,J=7.2Hz,2H,OCH2CH3),3.63(m,1H,CHN),1.93-1.67(4H,CH2CH2),1.24(t,J=7.2Hz,3H,CH3). 13C-NMR (150MHz, CDCl3): δ(ppm) 171.3,136.4,127.6,122.0,121.6,119.3,118.9,115.9,111.2,60.6,31.7,24.8,22.8,21.2,14.3. HRMS(ESI-TOF) m / z [M+H] + calcd for [C 15 H 21 N2O2] + 261.1603,found 261.1607. FT-IR (neat, cm -1 ): 3410,2928,1735,1679,1458,1339,1230,1201,1021,742.

[0116] Synthesis of JAX-108-Li [ka]

[0117] Lithium hydroxide (5.2 mg, 0.124 mmol) was added to a solution of JAX-106 (20.4 mg, 0.078 mmol) in methanol (0.3 mL) and HO (3.0 μL, 0.167 mmol) at room temperature, and the mixture was stirred for 1.5 hours. The reaction mixture was concentrated under reduced pressure, and the residue was washed with dehydrated methanol. The insoluble matter was concentrated to obtain the lithium salt of JAX-108 (4.7 mg, 25% yield).

[0118] Synthesis of methyl 2-((tert-butyldimethylsilyl)oxy)-5-(1H-indol-3-yl)pentanoate [ka]

[0119] Under an argon atmosphere, tert-butyldimethylsilyl chloride (TBSCl, 261 mg, 1.73 mmol) and 4-dimethylaminopyridine (DMAP, 6.4 mg, 0.052 mmol) were added to a solution of JAX-44 (129.6 mg, 0.52 mmol) and triethylamine (220 μL, 1.6 mmol) in DMF (2.7 mL) with stirring at 0° C. The reaction mixture was stirred at room temperature for 10 hours, and then saturated aqueous ammonium chloride solution (20 mL) was added. The mixture was extracted with diethyl ether (3×15 mL), and the organic phase was washed with saturated saline, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography (hexane:ethyl acetate = 10:1 to 9:1) to obtain methyl 2-((tert-butyldimethylsilyl)oxy)-5-(1H-indol-3-yl)pentanoate (154.9 mg, yield 82%) as a colorless oil.

[0120] 1 H-NMR(CDCl3,600MHz):δ(ppm) 7.95(brs,1H),7.60(d,J=7.8Hz,1H),7.35(d,J=8.4Hz,1H),7.19(m,1H),7.11(m,1H),6.97(m,1H) ),4.26(m,1H),3.70(s,3H),2.79(m,2H),1.92-1.76(4H),0.91(s,9H),0.08(s,3H),0.06(s,3H). 13 C-NMR(CDCl3,150MHz):δ(ppm) 174.4,136.3,127.5,121.8,121.1,119.1,118.9,116.3,111.0,72.2,51.7,35.0,25.7(3C),25.5,24.8,18.3,-5.0,-5.3. FT-IR (neat, cm -1 ): 3409,2951,2930,2855,1740,1457,1357,1254,1210,1124,1009,841,780,741,667.

[0121] Synthesis of benzyl 3-((tert-butyldimethylsilyl)oxy)-5-methoxy-5-oxopentyl)-1H-indole-1-carboxylate [ka]

[0122] Under an argon atmosphere, sodium hydride (51 mg, 1.28 mmol, 60% oil dispersion) was added to a solution of methyl 2-((tert-butyldimethylsilyl)oxy)-5-(1H-indol-3-yl)pentanoate (379 mg, 1.05 mmol) in DMF (5.3 mL) with stirring at 0°C. After stirring for 30 minutes at the same temperature, benzyl chloroformate (CbzCl, 180 μL, 1.27 mmol) was added. The reaction mixture was stirred at room temperature for 3 hours, and then saturated aqueous ammonium chloride solution (20 mL) was added. The mixture was extracted with diethyl ether (3×15 mL), and the organic phase was washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography (hexane:ethyl acetate = 20:1 to 15:1) to obtain benzyl 3-((tert-butyldimethylsilyl)oxy)-5-methoxy-5-oxopentyl)-1H-indole-1-carboxylate (439 mg, yield 84%) as a colorless oil.

[0123] 1 H-NMR(CDCl3,600MHz):δ(ppm) 8.16,(brs,1H),7.53-7.46(m,3H),7.44-7.35(m,4H),7.31(m,1H),7.24(m,1H),5.44(s,2H),4.23( m,1H),3.69(s,3H),2.70(t,J=6.6Hz,2H),1.91-1.73(m,4H),0.89(s,9H),0.07(s,3H),0.03(s,3H). 13C-NMR(CDCl3,150MHz):δ(ppm) 174.1,150.9,135.7,135.2,130.7,128.7(2C),128.6,128.4(2C),124.5,122.7,121.9 ,121.6,119.1,115.2,72.0,68.5,51.7,34.9,25.7(3C),24.6,24.5,18.3,-5.0,-5.4. FT-IR (neat, cm -1 ): 2951,2930,2855,1733,1454,1396,1356,1244,1127,1090,1022,836,748. HRMS(TOF) m / z [M+Na] + calcdfor [C 28 H 37 NNaO5Si] + 518.2339,found 518.2323.

[0124] Synthesis of benzyl 3-(4-hydroxy-5-methoxy-5-oxopentyl)-1H-indole-1-carboxylate [ka]

[0125] Under an argon atmosphere, TBAF (0.7 mL, 0.7 mmol, 1M THF solution) was added to a solution of benzyl 3-((tert-butyldimethylsilyl)oxy)-5-methoxy-5-oxopentyl)-1H-indole-1-carboxylate (171.3 mg, 0.33 mmol) in THF (1.7 mL) at 0°C. After stirring at the same temperature for 25 minutes, saturated aqueous ammonium chloride solution (20 mL) was added. The mixture was extracted with ethyl acetate (3 x 10 mL), and the organic phase was washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography (hexane:ethyl acetate = 10:1 to 6:1) to obtain colorless oily benzyl 3-(4-hydroxy-5-methoxy-5-oxopentyl)-1H-indole-1-carboxylate (106.8 mg, yield 85%).

[0126] 1 H-NMR(CDCl3,600MHz):δ(ppm) 8.17(brs,1H),7.54-7.47(m,3H),7.44-7.35(m,4H),7.32(m,1H),7.25(m,1H),5.44(s,2H) ,4.23(m,1H),3.75(s,3H),2.77-2.66(m,3H),1.93-1.83(m,2H),1.81(m,1H),1.73(m,1H). 13 C-NMR(CDCl3,150MHz):δ(ppm) 175.6,150.8,135.6,135.2,130.6,128.7(2C),128.6,128.4(2C),124.6 ,122.7,121.9,121.5,119.0,115.3,70.2,68.5,52.5,34.0,24.5,24.2. FT-IR (neat, cm -1 ): 3485,2949,1730,1453,1398,1357,1245,1095,1024,753,698. HRMS(TOF) m / z [M+Na] + calcd for [C 22 H 23 NNaO5] + 404.1474,found 404.1474.

[0127] Synthesis of benzyl 3-(5-methoxy-4,5-dioxopentyl)-1H-indole-1-carboxylate [ka]

[0128] Under an argon atmosphere, Dess-Martin periodinane (DMP, 116.3 mg, 0.27 mmol) was added to a solution of benzyl 3-(4-hydroxy-5-methoxy-5-oxopentyl)-1H-indole-1-carboxylate (69.7 mg, 0.18 mmol) and sodium bicarbonate (76.0 mg, 0.90 mmol) in methylene chloride (1.8 mL) at 0°C. After stirring at the same temperature for 3 hours, saturated aqueous sodium bicarbonate solution (10 mL) was added. The mixture was extracted with diethyl ether (3 x 10 mL), and the organic phase was washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography to obtain colorless oily benzyl 3-(5-methoxy-4,5-dioxopentyl)-1H-indole-1-carboxylate (67.4 mg, yield 97%).

[0129] 1 H-NMR(CDCl3,600MHz):δ(ppm) 8.17(brs,1H),7.54(d,J=8.4Hz,1H),7.51-7.48(m,2H),7.45-7.36(m,4H),7.33(m,1H),7.26(m,1H) ,5.45(s,2H),3.83(s,3H),2.93(t,J=7.2Hz,2H),2.74(t,J=7.8Hz,2H),2.07(tt,J=7.8,7.2Hz,2H). 13 C-NMR(CDCl3,150MHz):δ(ppm) 193.9,161.3,150.8,135.7,135.2,130.4,128.7(3C),128.5(2C),124.7,122.8,122.3,120.8,119.0,115.3,68.6,52.9,38.7,24.0,22.3. FT-IR (neat, cm -1 ): 2950,2361,1726,1452,1397,1357,1244,1082,1034,752,698. HRMS(TOF) m / z [M+Na] + calcd for [C 22 H 21 NNaO5]+ 402.1317,found 402.1333.

[0130] Synthesis of JAX-80 [ka]

[0131] Under a hydrogen atmosphere, a suspension of benzyl 3-(5-methoxy-4,5-dioxopentyl)-1H-indole-1-carboxylate (85.5 mg, 0.23 mmol) and Pd / C (10% by mass, 12.0 mg) in ethyl acetate (3.0 mL) was stirred at room temperature for 30 minutes. The reaction mixture was then filtered through Celite, pyridine (91 μL, 1.2 mmol) was added to the filtrate, and the mixture was concentrated under reduced pressure at less than 30° C. to approximately 3 mL. The resulting mixture was stirred at room temperature for 2 hours and concentrated under reduced pressure at less than 30° C. The residue was purified by silica gel flash column chromatography to obtain JAX-80 (43.9 mg, 80% yield) as a colorless solid.

[0132] 1 H-NMR(CDCl3,600MHz):δ(ppm) 7.98(brs,1H),7.60(d,J=7.8Hz,1H),7.36(d,J=7.8Hz,1H),7.20(m,1H),7.12(m,1H),6.99( m,1H),3.80(s,3H),2.91(t,J=7.2Hz,2H),2.83(t,J=7.5Hz,2H),2.09(tt,J=7.5,7.2Hz,2H). 13 C-NMR(CDCl3,150MHz):δ(ppm) 194.3,161.4,136.4,127.3,122.0,121.6,119.3,118.8,115.2,111.1,52.8,38.9,24.2,23.4. FT-IR (neat, cm -1 ): 3406,2945,2361,1726,1452,1270,1244,1087,744,670. HRMS(TOF) m / z [M+Na] + calcd for [C14 H 15 NNaO3] + 268.0950,found 268.0946.

[0133] Synthesis of 1-(methoxycarbonyl)-5-chloro-3-iodoindole [ka]

[0134] Under an argon atmosphere, crushed potassium hydroxide (1.02 g, 17.2 mmol) was added to a solution of 5-chloroindole (1.04 g, 6.9 mmol) in dehydrated DMF (11.5 mL) at room temperature. After stirring at the same temperature for 30 minutes, a solution of iodine (1.77 g, 6.9 mmol) in dehydrated DMF (2.1 mL) was added to the reaction mixture. The reaction mixture was stirred at room temperature for 6 hours, and ice water (230 mL) containing ammonium hydroxide (0.5%) and sodium sulfite (0.1%) was added. The mixture was extracted with a 1:1 mixture of n-hexane and ethyl acetate (3 x 150 mL), and the organic phase was washed with cold water (150 mL). After drying over anhydrous sodium sulfate and filtration, the filtrate was concentrated under reduced pressure to obtain 5-chloro-3-iodoindole as a yellow solid.

[0135] Triethylamine (14.6 mL, 0.33 M) and methyl chloroformate (1.79 mL, 5.37 mmol) were added to a solution of 5-chloro-3-iodoindole (2.14 g, 7.71 mmol) in dichloromethane (DCM; 48 mL) at 0° C. under an argon atmosphere. The reaction mixture was stirred at 0° C. for 10 minutes, then at room temperature for 30 minutes, and water was added to quench the reaction. The mixture was extracted with DCM (3×50 mL), and the organic phase was washed with water (30 mL) and then with saturated saline (30 mL), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel flash column chromatography (hexane:ethyl acetate=1:1) to obtain 1-(methoxycarbonyl)-5-chloro-3-iodoindole (2.22 g, 86% yield) as a brown solid.

[0136] 1 H-NMR(500MHz,CDCl3)δ(ppm) 8.05(d,J=8.0Hz,1H,Ar),7.74(s,1H,Ar),7.37(d,J=2.5Hz,1H,Ar),7.31(dd,J=2.3,8.8Hz,1H,Ar),4.04(s,3H,CH3). 13 C-NMR(125MHz,CDCl3)δ(ppm) 150.1,133.3,133,2,130.8,129.6,121.3(2C),116.1,65.1,54.2. FT-IR (neat, cm -1 ): 1734.7,1443.5,772.4,639.3.

[0137] Synthesis of ethyl 5-(5-chloro-1H-indol-3-yl)-2-hydroxypent-4-ynoate [ka]

[0138] A solution of 2-hydroxy-4-pentynoic acid ethyl (0.336 g, 2.36 mmol) in DMF (1.7 mL) was added to a solution of 1-(methoxycarbonyl)-5-chloro-3-iodoindole (0.66 g, 1.97 mmol), dichlorobis(triphenylphosphine)palladium(II) (6.92 mg, 0.0099 mmol) and copper(I) iodide (1.12 mg, 0.006 mmol) in triethylamine (10.3 mL) at 50° C. under an argon atmosphere. The reaction mixture was stirred at the same temperature for 33 hours and 25 minutes, and then 1N aqueous hydrochloric acid solution was added to the reaction mixture at 0° C. to stop the reaction. The mixture was extracted with diethyl ether (5×20 mL), and the organic phase was washed with saturated saline. This was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. Potassium carbonate (0.60 g, 4.14 mmol) was added to a solution of the crude product mixture in dehydrated ethanol (20 mL) at room temperature under an argon atmosphere while stirring. The reaction mixture was then stirred at room temperature for 15 hours, and aqueous ammonium chloride was added to the reaction mixture to quench the reaction. The mixture was extracted with diethyl ether (3×10 mL), and the organic phase was washed with saturated saline (10 mL). After drying over anhydrous sodium sulfate and filtration, the filtrate was concentrated under reduced pressure to give ethyl 5-(5-chloro-1H-indol-3-yl)-2-hydroxypent-4-ynoate (0.26 g, 45% yield).

[0139] Synthesis of JAX-93 [ka]

[0140] A solution of ethyl 5-(5-chloro-1H-indol-3-yl)-2-hydroxypent-4-ynoate (0.62 g, 2.13 mmol) and Pd / C (10% by mass, 0.68 g) in dehydrated ethanol (21 mL) was stirred for 1 hour at room temperature under a hydrogen atmosphere. The reaction mixture was then filtered twice through Celite, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel flash column chromatography (hexane:ethyl acetate=1:1 to methylene chloride:ethyl acetate=1:9) to obtain JAX-93 (8.3 mg, yield 1.4%) as a brown oil.

[0141] 1 H-NMR(600MHz,CDCl3)δ(ppm) 7.94(s,1H,Ar),7.54(s,1H,Ar),7.27(s,1H,Ar),7.13(d,J=9.0Hz,1H,Ar),7.01(s,1H,Ar),4.2 2(m,CHOH,3H,OCH2),2.75(m,3H,CH2,OH of Ar-CH2),1.81(m,4H,CH2),1.27(t,J=7.5Hz,3H,CH3). 13 C-NMR(125MHz,CDCl3)δ(ppm) 175.3,134.7,128.6,124.9,122.6,122.2,118.4,116.1,112.0,70.3,61.7,34.1,25.1,24.6,14.2. FT-IR (neat, cm -1 ): 3423.0,2980.5,2930.3,2861.8,1726.0,795.5.

[0142] Synthesis of 1-(methoxycarbonyl)-5-fluoro-3-iodoindole [ka]

[0143] Under an argon atmosphere, crushed potassium hydroxide (1.08 g, 19.2 mmol) was added to a solution of 5-fluoroindole (1.02 g, 7.54 mmol) in dehydrated DMF (11.5 mL) at room temperature. After stirring at the same temperature for 30 minutes, a solution of iodine (1.94 g, 7.64 mmol) in dehydrated DMF (2.1 mL) was added to the reaction mixture. The reaction mixture was stirred at room temperature for 6 hours, and ice water (230 mL) containing ammonium hydroxide (0.5%) and sodium sulfite (0.1%) was added. The mixture was extracted with a 1:1 mixture of n-hexane and ethyl acetate (3 x 150 mL), and the organic phase was washed with cold water (150 mL). After drying over anhydrous sodium sulfate and filtration, the filtrate was concentrated under reduced pressure to obtain 5-fluoro-3-iodoindole as a yellow solid.

[0144] Under an argon atmosphere, triethylamine (3.4 mL, 24.4 mmol) and methyl chloroformate (1.98 mL, 25.6 mmol) were added to a solution of 5-fluoro-3-iodoindole obtained in the above procedure in DCM (53.1 mL) at 0° C. The reaction mixture was stirred at 0° C. for 10 minutes, then stirred at room temperature for 20 hours, and water was added to quench the reaction. The mixture was extracted with DCM (3×50 mL), and the organic phase was washed with water (30 mL), and then with saturated saline (30 mL), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel flash column chromatography (hexane:ethyl acetate=1:1) to obtain 1-(methoxycarbonyl)-5-fluoro-3-iodoindole (2.38 g, yield 99%) as a brown solid.

[0145] 1 H-NMR(500MHz,CDCl3)δ(ppm) 8.11(s,1H,Ar),7.78(s,1H,Ar),7.10(m,2H,Ar),4.04(s,3H,COOCH3). 13 C-NMR(125MHz,CDCl3)δ(ppm) 159.8(d,J=240Hz),150.2,133.3(d,J=9.5Hz),131.1,116.2(d,J=8.4Hz),116.2(d,J=2.5Hz),107.3(d,J=23.9Hz),65.4(d,J=4.9Hz) FT-IR (neat, cm -1 ): 1747,1442,1252,614.

[0146] Synthesis of ethyl 5-(5-fluoro-1H-indol-3-yl)-2-hydroxypent-4-ynoate [ka]

[0147] Under an argon atmosphere, a solution of 1-(methoxycarbonyl)-5-fluoro-3-iodoindole (0.64 g, 2.00 mmol), dichlorobis(triphenylphosphine)palladium(II) (7.03 mg, 0.01 mmol) and copper(I) iodide (1.2 mg, 0.006 mmol) in triethylamine (10.4 mL) was added with a solution of 2-hydroxy-4-pentynoic acid ethyl (0.58 g, 4.1 mmol) in DMF (1.7 mL) at 50 ° C. After stirring the reaction mixture for 24 hours at the same temperature, the reaction was stopped by adding 1N aqueous hydrochloric acid to the reaction mixture at 0 ° C. The mixture was extracted with diethyl ether (5 × 20 mL) and the organic phase was washed with saturated saline. This was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. Under an argon atmosphere, potassium carbonate (0.73 g, 5.3 mmol) was added to a solution of the crude product mixture in dehydrated ethanol (20 mL) at room temperature while stirring. The reaction mixture was then stirred at room temperature for 6 hours, and an aqueous solution of ammonium chloride was added to the reaction mixture to quench the reaction. The mixture was extracted with ethyl acetate (3 x 10 mL), and the organic phase was washed with saturated saline (10 mL). After drying over anhydrous sodium sulfate and filtration, the filtrate was concentrated under reduced pressure to obtain a residue, which was purified by silica gel flash chromatography (hexane:ethyl acetate = 3:1) to obtain ethyl 5-(5-fluoro-1H-indol-3-yl)-2-hydroxypent-4-ynoate (0.214 g, yield 39%) as a yellow oil.

[0148] Synthesis of JAX-92 [ka]

[0149] A solution of ethyl 5-(5-fluoro-1H-indol-3-yl)-2-hydroxypent-4-ynoate (0.092 g, 0.33 mmol) and Pd / C (10% by mass, 9.2 mg) in dehydrated ethanol (3.29 mL) was stirred for 1 hour at room temperature under a hydrogen atmosphere. The reaction mixture was then filtered twice through Celite, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel flash column chromatography (hexane:ethyl acetate=1:1) to obtain JAX-92 (0.037 g, 40% yield) as a yellow oil.

[0150] 1 H-NMR(500MHz,CDCl3)δ(ppm) 7.91(brs,1H,Ar),7.26(m,2H,Ar),7.22(dd,J=2.75Hz,5.48Hz,1H,Ar),7.03(d,J=2.5Hz,1H,Ar),6.93(dt,J=2.5H z,9.0Hz,1H,Ar),4.22(m,3H,OCH2,CHO),2.75(m,3H,Ar-CH2 CH2,OH),1.80(m,4H,CH2),1.27(t,J=7.0Hz,3H,CH3).

[0151] Synthesis of 7-nitro-3-indole [ka]

[0152] At room temperature, crushed potassium hydroxide (1.7 g, 31 mmol) was added to a solution of 7-nitroindole (2.0 g, 12.3 mmol) in dehydrated DMF (21 mL). To this was added a solution of iodine (3.2 g, 12 mmol) in dehydrated DMF (3.7 mL). The reaction mixture was stirred at room temperature for 2.5 hours, and ice water (230 mL) containing ammonium hydroxide (0.5%) and sodium sulfite (0.1%) was added. The mixture was extracted with a 1:1 mixture of n-hexane and ethyl acetate (4 x 50 mL), and the organic phase was washed with cold water (150 mL). After drying over anhydrous sodium sulfate and filtration, the filtrate was concentrated under reduced pressure to obtain 7-nitro-3-iodoindole (3.5 g, 99% yield) as a yellow solid.

[0153] 1 H-NMR(600MHz,CDCl3):δ(ppm) 10.07(s,1H,NH),8.24(d,J=7.8Hz,1H,Ar),7.84(d,J=7.8Hz,1H,Ar),7.50(d,J=3.0Hz,1H,Ar),7.32(dd,J=7.8,7.8Hz,1H,Ar)

[0154] Synthesis of JAX-104 [ka]

[0155] A solution of 7-nitro-3-iodoindole (0.50 g, 1.74 mmol), dichlorobis(triphenylphosphine)palladium(II) (65 mg, 0.092 mmol) and copper(I) iodide (12 mg, 0.061 mmol) in triethylamine (9.0 mL) and DMF (1.0 mL) was added to a solution of ethyl 2-hydroxy-4-pentynoate (0.30 g, 2.1 mmol) in diethyl ether (1.8 mL) at 45°C under an argon atmosphere. The reaction mixture was stirred at the same temperature for 24 hours, and then 1N aqueous hydrochloric acid was added to the reaction mixture at 0°C to adjust the pH to 1 to stop the reaction. The mixture was extracted with diethyl ether (3 x 50 mL), and the organic phase was washed with saturated saline. This was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:diethyl ether=3:1) to obtain JAX-104 (0.34 g, yield 65%) as a yellow solid.

[0156] 1H-NMR(600MHz,CDCl3):δ(ppm) 9.89(s,1H,NH),8.18(d,J=8.4Hz,1H,Ar),8.05(d,J=8.4Hz,1H,Ar),7.51(d, J=1.6Hz,1H,Ar),7.28(dd,J=8.4,8.4Hz,1H,Ar),4.45(dd,J=11.4,4.8Hz,1H, CHO),4.26-4.37(2H,OCH2)3.20(d,J=6.0Hz,1H,OH),3.04(dd,J=17.4,4.8Hz, 1H,CC-CH2),2.98(dd,J=16.2,4.8Hz,1H,CC-CH2),1.33(t,J=6.6Hz,3H,CH3). 13 C-NMR (100MHz, CDCl3): δ(ppm) 173.3,133.2,132.2,129.6,128.4,128.0,120.1,119.9,100.4,86.8,74.8,69.1,62.1,62.2,14.2. HRMS(ESI-TOF) m / z [M+Na] + calcd for [C 15 H 14 N2NaO5] + 325.0800,found 325.0788. FT-IR (neat, cm -1 )3421,2981,2935,2236,1734,1547,1517,1483,1326,1234.

[0157] Synthesis of JAX-105 [ka]

[0158] A suspension of JAX-104 (0.051 g, 0.17 mmol) and Pd / C (10% by mass, 5.7 mg) in dehydrated ethanol (1.6 mL) was stirred for 26 hours at room temperature under a hydrogen atmosphere. The reaction mixture was then filtered through Celite, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate=3:1) to obtain JAX-105 (0.036 g, 77% yield) as a yellow oil.

[0159] 1 H-NMR(400MHz,CDCl3):δ(ppm) 9.71(s,1H,NH),8.59(s,2H,NH2),7.20(d,J=7.6Hz,1H,Ar),6.90(dd,J=8.0,7.6Hz,1H,Ar),6.84(s,1H,Ar),6.69(d,J=7.2Hz,1H,Ar),4.19-4.24(3H,CHO,OCH2),3.68(m,1H,OH),2.70-2.76(2H,Ar-CH2のCH2),1.67-1.92(4H,CH2),1.24(t,J=7.2Hz,3H,CH3) 13 C-NMR(125MHz,CDCl3):δ(ppm) 176.0,130.2,129.3,128.1,121.9,120.4,117.5,112.1,109.7,71.0,62.2,34.8,25.7,25.4,14.7. HRMS(ESI-TOF) m / z [M+H] + calcd for [C 15 H 21 N2O3] + 277.1552,found 277.1555. FT-IR(neat、cm -1 )3337,2929,2857,2360,1729,1631,1444,1370,1230,1099.

Claims

1. A compound represented by the following formula (1) or a salt thereof with an acidic compound: [Case 1] (In the above general formula (1), each R 1 are each independently an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; A is -OR 2 Or -O - X + and R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms; X + Li + , Na + , K + , N.H. 4 + Or N + R 5 4 and R 3 and R 4 provided that one of them is a hydrogen atom and the other is a hydroxyl group or an amino group, or together form a (=O) group, and each R 5 are each independently a hydrogen atom or an alkyl group having 5 or less carbon atoms, and n is an integer from 0 to 4.

2. A compound represented by any of the following chemical formulas or a salt thereof with an acidic compound. [Case 2]

3. A compound represented by any of the following chemical formulas or a salt thereof with an acidic compound. [C3]

4. A plant growth regulator comprising the compound according to any one of claims 1 to 3 or a salt thereof with an acidic compound.

5. 5. The plant growth regulator according to claim 4, wherein the plant growth is the formation or elongation of lateral roots and root hairs.

6. A method for producing the compound according to claim 1, comprising the steps of: Step (a): A step of obtaining a compound represented by the following general formula (C) by cross-coupling compounds represented by the following general formulas (A) and (B): [C4] (In general formula (A), each R 1 are each independently an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; X is a halogen atom; R p is a hydrogen atom or a protecting group for the nitrogen of the indole ring, and n is an integer from 0 to 4. [C5] (In general formula (B), R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, R 3p is a hydroxyl group or an amino group which may have a protecting group. [C6] (In general formula (C), R 1 is an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, R 3p is a hydroxyl group or an amino group which may have a protecting group, R p is a hydrogen atom or a protecting group for the nitrogen of the indole ring, and n is an integer from 0 to 4. Step (b): A step of obtaining a compound represented by the following general formula (D) by reducing the compound represented by the general formula (C): [C7] (In general formula (D), R 1 is an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, R 3p is a hydroxyl group or an amino group which may have a protecting group, R p is a hydrogen atom or a protecting group for the nitrogen of the indole ring, and n is an integer from 0 to 4. Step (c): In the compound represented by the general formula (D), R p is a hydrogen atom, and R 3p In the case where the hydroxyl group or amino group represented by the formula (I) does not have a protecting group, this step is not carried out. In other cases, the compound represented by the formula (D) is deprotected to obtain a compound represented by the formula (E) below. [C8] (In general formula (E), R 1 is an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, R 3 is a hydroxyl group or an amino group, and n is an integer from 0 to 4.

7. A method for producing the compound according to claim 1, comprising the steps of: Step (d): A step of obtaining a compound represented by the following general formula (G) by reducing a compound represented by the following general formula (F): [C9] (In general formula (F), each R 1 are each independently an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; R p is a protecting group for the indole ring nitrogen, R 6 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and n is an integer of 0 to 4. [C10] (In general formula (G), each R 1 are each independently an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; R p is a protecting group for the indole ring nitrogen, and n is an integer from 0 to 4. Step (e): A step of reacting a compound represented by the general formula (G) with a cyanide anion to obtain a compound represented by the following general formula (H): [C11] (In general formula (H), each R 1 are each independently an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; R p is a protecting group for the indole ring nitrogen, and n is an integer from 0 to 4. Step (f): A step of hydrolyzing the cyano group present in the compound represented by the general formula (H) by reacting the compound represented by the general formula (H) with an acid or a base in the presence or absence of an alcohol having 1 to 5 carbon atoms to obtain a compound represented by the following general formula (I): [C12] (In general formula (I), R 1 is an amino group, a halogen atom, a nitro group, an alkyl group having 1 to 5 carbon atoms, a hydroxyl group, or an alkoxy group having 1 to 5 carbon atoms; R 2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and n is an integer of 0 to 4.

Citation Information

Cited By

  • Magnetic disk device and method

    CN121708969A